Round co-led by BGF, Octopus Ventures and M Ventures, with support from new corporate investor, Eli Lilly and Company, and ...
MoonLake Immunotherapeutics to host a Capital Markets Updateon Wednesday, September 11ZUG, Switzerland, September 9, 2024 – MoonLake ...
NanoSyrinx, the synthetic biology company developing ‘nanosyringes’ as a novel platform for targeted intracellular delivery ...
MoonLake Immunotherapeutics to host a Capital Markets Updateon Wednesday, September 11 ZUG, Switzerland, September 9, 2024 - MoonLake Immunotherapeutics AG ("MoonLake"; Nasdaq: MLTX), a clinical-stage ...